Welcome to kongre.net
Speaker
Chief Executive Officer, Arbor Biotechnologies
Devyn Smith, Chief Executive Officer at Arbor Biotechnologies, spoke at 7th Genome Editing Therapeutics Summit 2026 (Boston, United States of America, 29–30 Sept 2026) in the session “Fireside Chat: Transitioning Gene Editing Therapeutics from Bespoke Treatments to Platform Approaches for Broader Disease Indications & Commercial Sustainability”.
29–30 Sept 2026Boston, United States of America
Associate Director, Sanofi
Senior Scientist, AbbVie
Senior Director, Scribe Therapeutics
Senior Director, Technical Operations, eGenesis Bio
Senior Director, Clinical Bioanalytics & Translational Science, Beam Therapeutics
Senior Scientist, Bristol Myers Squibb
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Devyn Smith, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].